Dr. Annick Töpken holds a doctorate in biology and has been working in intellectual property law since 2001. She joined the team of Wallinger Ricker Schlotter Tostmann in 2021.
Dr. Töpken was admitted to practice as a German Patent Attorney in 2005 and as a European Patent Attorney in 2008. Dr. Töpken's areas of practice include the prosecution of European and international patent applications and the enforcement and defense of intellectual property rights in opposition and appeal proceedings. She also has extensive experience in drafting patent applications and coordinating international application proceedings and patent portfolios. Due to her experience in an industrial patent department, she is also familiar with the corporate view of industrial property rights.
Dr. Töpken studied biology at the Biozentrum of the University of Basel. Her main fields of study were biochemistry, biophysical chemistry, genetics and cell biology. She then completed her PhD in molecular neuroscience at the Institute of Cell Biology at ETH Zurich.
Dr. Töpken's technical expertise mainly includes biotechnology, drugs (small molecules, proteins, miRNA) and their medical applications, plants, formulations, antibodies, vaccines, gene therapy, stem cells, expression systems and diagnostic methods.
Patent Attorney at the law firm Wallinger Ricker Schlotter Tostmann
Patent Attorney in the law firm Weickmann & Weickmann, Munich
Freelance work as Patent Attorney
Trained as a Patent Attorney at the law firm df-mp, at the Munich Higher Regional Court, at the German Patent and Trademark Office and at the Federal Patent Court
Patent Clerk, Switch Biotech AG, Martinsried, Germany
Doctorate at the ETH Zurich
Study of biology at the Biozentrum of the University of Basel